Skip to main content

General Psychiatry

Some 18.1% of patients who tested positive for COVID-19 in the United States were diagnosed with a psychiatric disorder within 3 months, according to a study published in The Lancet Psychiatry.
Although loneliness affects a slate of health outcomes, its strongest effects appear to target mental health and overall well-being, according to a comprehensive review and meta-analysis published online in Psychiatry Research.
Positive tests for non-prescribed use of fentanyl and opioids, as well as heroin, increased during the early months of the COVID-19 pandemic, according to a recently published study of nearly 900,000 de-identified lab results conducted by Quest Diagnostics. Use of fentanyl in combination with other drugs also surged.
Scientists from 3 diverse disciplines at Purdue University, West Lafayette, Indiana, have developed a new material that can sense the neurotransmitter glutamate in the brain.
SPONSORED CONTENT
As part of its commitment to nurse practitioners (NPs) who are treating patients with mental illness, AbbVie today announced the launch of NP Psych Navigator, a centralized resource that connects NPs with tools to help them identify mental illness…
At Psych Congress Elevate, Psych Congress Steering Committee member Saundra Jain, MA, PsyD, LPC, discussed clinician burnout and using wellness practices as a possible antidote. In this podcast, she…
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, speaks with general psychiatrist Abbey Strauss, MD, MSW, about the history, chemistry, and potential use of the neurotransmitter…
In this podcast, Michael F. Myers, MD interviews fellow psychiatrists John Budin, MD, and John S. Tamerin, MD, about mental health professionals living with psychiatric illness and how their needs…
Back to Top